InvestmentPitch Media Video Discusses LOVE Pharma's Shareholders' Letter from CEO Zach Stadnyk Pharmaceutical Investing
Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors Psychedelics Investing
Goodness Growth Holdings Announces Launch of Boundary Waters Pre-Rolls in Minnesota Psychedelics Investing
Awakn Life Sciences Signs Agreement with a Leading Drug Development Company to Deepen IP Moat for Its Lead Program Company News
Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson's Research for SLS-004 Psychedelics Investing
BetterLife Lead Drug Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects Pharmaceutical Investing
Another Public Company First: Silo Wellness Opens Jamaican Ecotourism Psilocybin Microdosing Resort for the Psychedelic Curious; Shareholder Discounts for Psychedelic Vacations Available Psychedelics Investing
Lobe Sciences Announces Update on Corporate Slide Deck Highlighting its Psilocin Compounds and Development Plans Pharmaceutical Investing
Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
